Molecular Mechanisms in Progressive Idiopathic Pulmonary Fibrosis

被引:90
|
作者
Steele, Mark P. [1 ]
Schwartz, David A. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Lung Transplant Program, Div Allergy Pulm & Crit Care Med, Nashville, TN 37332 USA
[2] Univ Colorado, Sch Med, Aurora, CO 80045 USA
[3] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA
来源
关键词
familial pulmonary fibrosis; familial interstitial pneumonia; telomerase; surfactant proteins; mucin; 5B; SURFACTANT-PROTEIN-C; NONSPECIFIC INTERSTITIAL PNEUMONIA; ENDOPLASMIC-RETICULUM STRESS; ALVEOLAR EPITHELIAL-CELLS; DYSKERATOSIS-CONGENITA; GENE; MUTATIONS; DISEASE; RISK; SUSCEPTIBILITY;
D O I
10.1146/annurev-med-042711-142004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There is clear evidence that environmental exposures and genetic predisposition contribute to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Cigarette smoking increases the risk of developing IPF several-fold, as do other exposures such as metal-fume and wood-dust exposure. Occupations that increase the risk of IPF are agricultural work, hairdressing, and stone polishing, supporting the role of environmental exposure in disease pathogenesis. Genetic predisposition to IPF is evident from its familial aggregation and the fact that pulmonary fibrosis develops in several rare genetic disorders. Mutations in surfactant proteins lead to pulmonary fibrosis and are associated with endoplasmic reticulum stress in alveolar type II epithelial cells. Mutations in telomerase have been found in several families with IPF, and shortened telomeres are found in sporadic cases of IPF. A common variant in mucin 5B predisposes to both familial and sporadic IPF and is present in the majority of cases, indicating sporadic IPF occurs in those with genetic predisposition.
引用
收藏
页码:265 / 276
页数:12
相关论文
共 50 条
  • [1] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
  • [2] Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
    Zhang, Yihang
    Wang, Jiazhen
    ADVANCES IN RESPIRATORY MEDICINE, 2023, 91 (01) : 26 - 48
  • [3] IDIOPATHIC PROGRESSIVE PULMONARY FIBROSIS
    DAVIES, D
    CROWTHER, JS
    MACFARLANE, A
    THORAX, 1975, 30 (03) : 316 - 325
  • [4] Integrated analysis of the molecular mechanisms in idiopathic pulmonary fibrosis
    Zhu, Ke
    Xu, Aiqun
    Xia, Wanli
    Li, Pulin
    Han, Rui
    Wang, Enze
    Zhou, Sijing
    Wang, Ran
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (15): : 3412 - 3424
  • [5] Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosis
    Fang, Yue
    Tian, Jingya
    Fan, Yumei
    Cao, Pengxiu
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (12) : 9811 - 9820
  • [6] Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosis
    Yue Fang
    Jingya Tian
    Yumei Fan
    Pengxiu Cao
    Molecular Biology Reports, 2020, 47 : 9811 - 9820
  • [7] Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Liu, Gabrielle Y.
    Budinger, G. R. Scott
    Dematte, Jane E.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [8] Antifibrotic therapy for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Teoh, A.
    Glenn, L.
    Corte, T.
    Holland, A.
    RESPIROLOGY, 2023, 28 : 202 - 202
  • [9] Dyspnoea with progressive "idiopathic" pulmonary fibrosis
    Puri, Chahat
    Harish, Vignesh
    Rhee, Kyunghoon
    Slack, Donald F.
    RESPIROLOGY CASE REPORTS, 2021, 9 (07):
  • [10] Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches
    Glass, Daniel S.
    Grossfeld, David
    Renna, Heather A.
    Agarwala, Priya
    Spiegler, Peter
    Kasselman, Lora J.
    Glass, Amy D.
    DeLeon, Joshua
    Reiss, Allison B.
    RESPIRATORY INVESTIGATION, 2020, 58 (05) : 320 - 335